Overlap of Five Chronic Pain Conditions: Temporomandibular Disorders, Headache, Back Pain, Irritable Bowel Syndrome, and Fibromyalgia

Aims: To assess cohort retention in the OPPERA project and to compare the degree of overlap between pairs of chronic overlapping pain conditions (COPCs) using a cross-sectional analysis of data from 655 adults who completed follow-up in the OPPERA study. Methods: Subjects were classified for the absence or presence of each of the five COPCs. The extent of overlap beyond chance was quantified using odds ratios, which were calculated using binary logistic regression models. Results: While overlap was the norm, its magnitude varied according to COPC: 51% of people with headache had one or more overlapping COPCs, and this proportion increased to 90% for people with fibromyalgia. The degree of overlap between pairs of COPCs also varied considerably, with odds ratios being greatest for associations between musculoskeletal conditions (fibromyalgia, temporo mandibular disorders, and low back pain) and less pronounced for overlap involving headache or IBS. Furthermore, univariate associations between some pairs of COPCs were nullified after adjusting for other COPCs. Conclusion: There was greater overlap between fibromyalgia and either temporomandibular disorders or low back pain than between other pairs of COPCs. While musculoskeletal conditions exhibited some features that could be explained by a single functional syndrome, headache and irritable bowel syndrome did not.

back pain; fibromyalgia; irritable bowel syndrome; temporomandibular disorder

1. Aggarwal VR, McBeth J, Zakrzewska JM, Lunt M, Macfarlane GJ. The epidemiology of chronic syndromes that are frequently unexplained: Do they have common associated factors? Int J Epidemiol 2006;35:468–476.

2. Diatchenko L, Nackley AG, Slade GD, Fillingim RB, Maixner W. Idiopathic pain disorders—Pathways of vulnerability. Pain 2006;123:226–230.

3. Maixner W, Fillingim RB, Williams DA, Smith SB, Slade GD. Overlapping chronic pain conditions: Implications for diagnosis and classification. J Pain 2016;17(9 suppl):T93–T107.

4. Yunus MB. Editorial review: An update on central sensitivity syndromes and the issues of nosology and psychobiology. Curr Rheumatol Rev 2015;11:70–85.

5. Mayer EA, Bushnell MC. Functional Pain Syndromes: Presentation and Pathophysiology. IASP, 2015.

6. NIH Working Group. Chronic Overlapping Pain Conditions. Summary of NIH Work Group Meeting to Develop Case Definition & Common Data Elements. National Institutes of Health, 2015. https://www.iprcc.nih.gov/sites/default/files/Veasley- COPC.pdf. Accessed May 8, 2020.

7. Valderas JM, Starfield B, Sibbald B, Salisbury C, Roland M. Defining comorbidity: Implications for understanding health and health services. Ann Fam Med 2009;7:357–363.

8. Aaron LA, Buchwald D. A review of the evidence for overlap among unexplained clinical conditions. Ann Intern Med 2001;134:868–881.

9. Woolf CJ. Central sensitization: Implications for the diagnosis and treatment of pain. Pain 2011;152(3 suppl):s2–s15.

10. Williams DA. Phenotypic features of central sensitization. J Appl Biobehav Res 2018;23(2). pii: e12135.

11. von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies. J Clin Epidemiol 2008;61:344–349.

12. Fillingim RB, Slade GD, Greenspan JD, et al. Long-term changes in biopsychosocial characteristics related to tem-poromandibular disorder: Findings from the OPPERA study. Pain 2018;159:2403–2413.

13. Bair E, Brownstein NC, Ohrbach R, et al. Study protocol, sam-ple characteristics, and loss to follow-up: The OPPERA prospective cohort study. J Pain 2013;14(12 suppl):T2–T19.

14. Slade GD, Bair E, By K, et al. Study methods, recruitment, sociodemographic findings, and demographic representativeness in the OPPERA study. J Pain 2011;12(11 suppl):T12–T26.

15. Schiffman E, Ohrbach R, Truelove E, et al. Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) for clinical and research applications: Recommendations of the International RDC/TMD Consortium Network* and Orofacial Pain Special Interest Group. J Oral Facial Pain Headache 2014;28:6–27.

16. Headache Classification Committee of the International Head-ache Society (IHS). The International Classification of Headache Disorders, 3rd edition. Cephalalgia 2018;38:1–211.

17. Lipton RB, Dodick D, Sadovsky R, et al. A self-administered screener for migraine in primary care: The ID Migraine validation study. Neurology 2003;61:375–382.

18. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastro-enterology 2006;130:1480–1491.

19. Dionne CE, Dunn KM, Croft PR, et al. A consensus approach toward the standardization of back pain definitions for use in prevalence studies. Spine (Phila Pa 1976) 2008;33:95–103.

20. Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibro-myalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990;33:160–172.

21. Wolfe F, Clauw DJ, Fitzcharles MA, et al. Fibromyalgia criteria and severity scales for clinical and epidemiological studies: Amodification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia. J Rheumatol 2011;38:1113–1122.

22. Isong U, Gansky SA, Plesh O. Temporomandibular joint and muscle disorder-type pain in U.S. adults: The National Health Interview Survey. J Orofac Pain 2008;22:317–322.

23. Janal MN, Raphael KG, Nayak S, Klausner J. Prevalence of myofascial temporomandibular disorder in US community women. J Oral Rehabil 2008;35:801–809.

24. Richardson DB, Rzehak P, Klenk J, Weiland SK. Analyses of case-control data for additional outcomes. Epidemiology 2007;18:441–445.

25. Monsees GM, Tamimi RM, Kraft P. Genome-wide association scans for secondary traits using case-control samples. Genet Epidemiol 2009;33:717–728.

26. Rapoport AM, Bigal ME. ID-migraine. Neurol Sci 2004;25(sup-pl 3):s258–s260.

27. Jensen R, Stovner LJ. 2008. Epidemiology and comorbidity of headache. Lancet Neurol 2008;7:354–361.

28. Von Korff M, Dworkin SF, Le Resche L, Kruger A. An epidemiologic comparison of pain complaints. Pain 1988;32:173–183.

29. Wilson S, Roberts L, Roalfe A, Bridge P, Singh S. Prevalence of irritable bowel syndrome: A community survey. Br J Gen Pract 2004;54:495–502.

30. Visscher CM, Ligthart L, Schuller AA, et al. Comorbid disorders and sociodemographic variables in temporomandibular pain in the general Dutch population. J Oral Facial Pain Headache 2015;29:51–59.

31. Scher AI, Stewart WF, Lipton RB. The comorbidity of headache with other pain syndromes. Headache 2006;46(9):1416–1423.

32. Riedl A, Schmidtmann M, Stengel A, et al. Somatic comorbidities of irritable bowel syndrome: A systematic analysis. J Psychosom Res 2008;64:573–582.

33. Yunus MB. 2012. The prevalence of fibromyalgia in other chronic pain conditions. Pain Res Treat 2012;2012:584573.

34. Aaron LA, Burke MM, Buchwald D. Overlapping conditions among patients with chronic fatigue syndrome, fibromyalgia, and temporomandibular disorder. Arch Intern Med 2000; 160:221–227.

35. Dadabhoy D, Clauw DJ. Therapy insight: Fibromyalgia—A different type of pain needing a different type of treatment. Nat Clin Pract Rheumatol 2006;2:364–372.

36. Slade GD, Ohrbach R, Greenspan JD, et al. Painful temporo-mandibular disorder: Decade of discovery from OPPERA studies. J Dent Res 2016;95:1084–1092.